Norman W. Baylor，PhD

Dr. Norman W. Baylor is the President and CEO of Biologics Consulting Group, Inc. responsible for managing a team of consultants who provides national and international regulatory, clinical and product development advice on the commercial production of biological, pharmaceutical and device products.  Prior to joining Biologics Consulting, Dr. Baylor was the Director of the Office of Vaccines Research and Review (OVRR) in the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER). During his 20-year tenure at FDA he evaluated and facilitated the development and licensure of numerous vaccines including acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV), influenza, and Zoster. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, the US Department of Health and Human Services National Vaccine Advisory Committee, the Advisory Commission on Childhood Vaccines, and as a member of the National Institutes of Health NIAID Advisory Council. He also serves as an expert advisor to the World Health Organization on global vaccine initiatives. Dr. Baylor was a member of PATH Malaria Vaccine Initiative’s Vaccine Science Portfolio Advisory Council, and is currently a board member of the Infectious Disease Research Institute (IDRI) in Seattle, Washington.